The Safety of Prescription Drugs

JAMA. 2015 Jul 21;314(3):233-4. doi: 10.1001/jama.2015.7151.

Authors

Joshua M Sharfstein¹, Aaron S Kesselheim²

Affiliations

¹ Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² The Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.

PMID: 26197182
DOI: 10.1001/jama.2015.7151

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Hypoglycemic Agents / adverse effects*
Male
Pancreatic Neoplasms / chemically induced*
Prostatic Neoplasms / chemically induced*
Thiazolidinediones / adverse effects*
Urinary Bladder Neoplasms / chemically induced*

Substances

Hypoglycemic Agents
Thiazolidinediones